| Literature DB >> 24697746 |
Malin Blomstrand1, Erik Holmberg, Maria A I Aberg, Marie Lundell, Thomas Björk-Eriksson, Per Karlsson, Klas Blomgren.
Abstract
UNLABELLED: While the detrimental effects of cranial radiotherapy on the developing brain are well known, the effects on cognitive performance of low doses of ionizing radiation is less studied. We performed a population-based cohort study to determine whether low doses of ionizing radiation to the brain in infancy affects cognitive function later in life. Further we hypothesized that the dose to the hippocampus predicts cognitive late side effects better than the anterior or the posterior brain doses.Entities:
Mesh:
Year: 2014 PMID: 24697746 PMCID: PMC4219853 DOI: 10.3109/0284186X.2014.899434
Source DB: PubMed Journal: Acta Oncol ISSN: 0284-186X Impact factor: 4.089
Figure 1.Inclusion and exclusion criteria in the study.
Figure 2.For each patient the estimated absorbed dose to the anterior brain, the posterior brain and the hippocampus was calculated. The number of subjects in each dose category (mGy) is shown, separated into the anterior brain (green), posterior brain (blue) and the hippocampus (red).
Estimated absorbed doses (mGy) to different parts of the brain. Cohort for analysis of military tests as outcome.
| Part of brain Dose category (mGy) | Anterior | Posterior | Hippocampus | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Number | Mean dose (mGy) | Median dose (mGy) | Number | Mean dose (mGy) | Median dose (mGy) | Number | Mean dose (mGy) | Median dose (mGy) | |
| 0 | 785 | 0 | 0 | 845 | 0 | 0 | 825 | 0 | 0 |
| 1–20 | 986 | 14 | 10 | 1000 | 14 | 10 | 765 | 14 | 10 |
| 21–100 | 678 | 48 | 40 | 931 | 56 | 50 | 1093 | 55 | 50 |
| 100–250 | 437 | 166 | 160 | 171 | 151 | 140 | 256 | 148 | 140 |
| 250– | 144 | 675 | 363 | 83 | 652 | 420 | 91 | 1105 | 680 |
| Totals | 3030 | 71 | 20 | 3030 | 48 | 20 | 3030 | 69 | 20 |
Figure 3.Results from the Swedish Military Service Conscription Register Data from the cognitive test for the 3030 subjects, separated into the five dose categories. The results are plotted based on the dose to the anterior brain (green), the posterior brain (blue) and the hippocampus (red). The tests results were adjusted for age at treatment and year of birth. The error bars indicate standard error. (A) Results from the logical test. P for trend: anterior 0.12, posterior 0.79 and hippocampus 0.09. (B) Results from the verbal test. P for trend: anterior 0.02, posterior 0.97 and hippocampus 0.005. (C) Results from the spatial test. P for trend: anterior 0.70, posterior 0.58 and hippocampus 0.35. (D) Results from the technical test. P for trend: anterior 0.45, posterior 0.81 and hippocampus 0.18. (E) Combined results from the four tests, yielding a global score. P for trend: anterior 0.23, posterior 0.91 and hippocampus 0.06.
Higher education in relation to dose, part of the brain and parents’ education. The numbers represent absolute values and in brackets the proportion of individuals with higher education is shown.
| Dose (mGy) | No in cohort | Parents without higher education | Parents with higher education |
|---|---|---|---|
| Anterior | 2559 (0.25) | 2103 (0.19) | 456 (0.53) |
| 0 | 657 (0.27) | 510 (0.19) | 147 (0.52) |
| 1–20 | 843 (0.24) | 714 (0.18) | 129 (0.54) |
| > 20–100 | 573 (0.28) | 465 (0.22) | 108 (0.51) |
| > 100–250 | 359 (0.23) | 312 (0.20) | 47 (0.45) |
| > 250 | 127 (0.25) | 102 (0.15) | 25 (0.68) |
| Posterior | 2559 (0.25) | 2103 (0.19) | 456 (0.53) |
| 0 | 710 (0.27) | 550 (0.19) | 160 (0.52) |
| 1–20 | 856 (0.24) | 727 (0.18) | 129 (0.54) |
| > 20–100 | 776 (0.26) | 639 (0.21) | 137 (0.48) |
| > 100–250 | 153 (0.24) | 134 (0.19) | 19 (0.63) |
| > 250 | 64 (0.27) | 53 (0.17) | 11 (0.73) |
| Hippocampus | 2559 (0.25) | 2103 (0.19) | 456 (0.53) |
| 0 | 696 (0.27) | 541 (0.20) | 155 (0.53) |
| 1–20 | 653 (0.25) | 551 (0.19) | 102 (0.56) |
| > 20–100 | 923 (0.24) | 769 (0.19) | 154 (0.47) |
| > 100–250 | 208 (0.28) | 175 (0.22) | 33 (0.64) |
| > 250 | 79 (0.24) | 67 (0.16) | 12 (0.67) |
Odds ratios and 95% confidence intervals of higher education, in relation to dose.
| Dose (mGy) | Crude odds ratio (95% CI) | Multivariate* odds ratio (95% CI) |
|---|---|---|
| Anterior | n = 2559 | n = 2559 |
| 0 | 1.00 | 1.00 |
| 1–20 | 0.86 (0.68–1.09) | 0.97 (0.75–1.24) |
| > 20–100 | 1.05 (0.82–1.35) | 1.09 (0.83–1.42) |
| > 100–250 | 0.84 (0.62–1.13) | 0.97 (0.70–1.33) |
| > 250 | 0.93 (0.60–1.44) | 0.88 (0.56–1.41) |
| Odds ratio per 50 mGy | 0.99 (0.97–1.02) | 0.99 (0.97–1.02) |
| Posterior | n = 2559 | n = 2559 |
| 0 | 1.00 | 1.00 |
| 1–20 | 0.86 (0.68–1.08) | 0.97 (0.76–1.23) |
| > 20–100 | 0.96 (0.76–1.21) | 1.02 (0.79–1.30) |
| > 100–250 | 0.87 (0.65–1.31) | 1.00 (0.65–1.54) |
| > 250 | 0.99 (0.55–1.77) | 1.02 (0.55–1.89) |
| Odds ratio per 50 mGy | 0.99 (0.95–1.02) | 0.99 (0.95–1.02) |
| Hippocampus | n = 2559 | n = 2559 |
| 0 | 1.00 | 1.00 |
| 1–20 | 0.90 (0.70–1.15) | 1.00 (0.77–1.30) |
| > 20–100 | 0.85 (0.68–1.07) | 0.91 (0.71–1.15) |
| > 100–250 | 1.07 (0.76–1.51) | 1.18 (0.82–1.69) |
| > 250 | 0.86 (0.50–1.47) | 0.88 (0.50–1.55) |
| Odds ratio per 50 mGy | 1.00 (0.99–1.02) | 1.00 (0.99–1.02) |
*Adjusted for age at treatment, year at birth and parents’ education.